CME Group Posts Higher Revenue, Net Income, and Diluted EPS Year-Over-Year in Interim Filing, With Mixed Operating-Income Signal

Bottom line

- For CME GROUP INC. (CME), the 10-Q filed for period-ended-2026-06-30 under accession 0001156375-26-000047 shows higher revenue, operating income, net income, and diluted earnings per share in the six-month year-to-date period versus the prior-year comparative, and higher revenue, net income, and diluted earnings per share with lower operating income in the three-month reporting period versus the prior-year comparative. - Revenues were $1,706,200,000 USD in the three-month reporting period (the three months ended June 30, 2026), higher than the prior-year comparative of $1,692,000,000 USD (the three months ended June 30, 2025).

- Revenues were $3,586,300,000 USD in the six-month year-to-date period (the six months ended June 30, 2026), higher than the prior-year comparative of $3,334,300,000 USD (the six months ended June 30, 2025). - Operating Income (Loss) was $1,107,100,000 USD in the three-month reporting period (the three months ended June 30, 2026) versus $1,129,300,000 USD in the prior-year comparative (the three months ended June 30, 2025), a year-over-year decline from profit to profit. - Operating Income (Loss) was $2,416,800,000 USD in the six-month year-to-date period (the six months ended June 30, 2026) versus $2,237,300,000 USD in the prior-year comparative (the six months ended June 30, 2025), a year-over-year gain from profit to profit.

- Net Income (Loss) Attributable to Parent was $1,041,800,000 USD in the three-month reporting period (the three months ended June 30, 2026) versus $1,025,100,000 USD in the prior-year comparative (the three months ended June 30, 2025), a year-over-year gain from profit to profit. - Net Income (Loss) Attributable to Parent was $2,196,100,000 USD in the six-month year-to-date period (the six months ended June 30, 2026) versus $1,981,300,000 USD in the prior-year comparative (the six months ended June 30, 2025), a year-over-year gain from profit to profit.

81 per diluted share USD/SHARES in the prior-year comparative (the three months ended June 30, 2025), a year-over-year gain from profit to profit. 43 per diluted share USD/SHARES in the prior-year comparative (the six months ended June 30, 2025), a year-over-year gain from profit to profit. - The filing evidence does not attribute this change to any single cause.

- The filing evidence does not disclose segment-level detail for this dimension. - The filing evidence contains no peer or industry comparison. - Identity context for this section: CIK 0001156375, form 10-Q, fiscal period period-ended-2026-06-30, accession 0001156375-26-000047, ticker CME.

's 10-Q filing; readers can cross-reference related interim results such as Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in the reporting period Filing for additional comparative context.

Financial performance

- Reported figures for CME GROUP INC. in this 10-Q for period-ended-2026-06-30, filed under accession 0001156375-26-000047 (CIK 0001156375, ticker CME), present the income statement with a year-over-year improvement across the headline metrics for both the three-month and six-month presentations. Revenues were $1,706,200,000 for the three-month reporting period the three months ended June 30, 2026, higher than $1,692,000,000 in the prior-year quarter the three months ended June 30, 2025.

For the six-month year-to-date period the six months ended June 30, 2026, revenues were $3,586,300,000, higher than $3,334,300,000 in the six months ended June 30, 2025. - Operating Income (Loss) was $1,107,100,000 for the quarter and $2,416,800,000 for the half-year, compared with $1,129,300,000 and $2,237,300,000 respectively. Net Income (Loss) Attributable to Parent was $1,041,800,000 in the three months ended June 30, 2026 and $2,196,100,000 in the six months ended June 30, 2026, versus $1,025,100,000 and $1,981,300,000 in the prior-year comparables; each pair stayed in profit territory on both sides of the comparison.

43 per diluted share in the prior-year periods; both stayed profitable on both sides of the move. - The authorized year-over-year shape frames the period as broadly higher at the top line, higher at the operating-income and net-income levels for the six-month comparison, with the three-month operating-income comparison the only authorized move in the opposite direction. Management's framing in the filing leans on forward-looking language such as "believe," "anticipate," "estimate," "expect," "may," "plan," "intend" and "could," and it cautions that actual outcomes may differ materially from projections.

- No quantitative forward guidance is disclosed for the next reporting period within this filing. Forward-looking statements are limited to general cautionary language about competitive, financial and economic data, current expectations, estimates and projections, and a reminder that statements are not guarantees of future performance. Specific revenue, operating-income, EPS or capital-return targets for the upcoming quarter or full year are not stated, so any forward expectations beyond the cautionary framing are not provided.

- The accounting context is a standard interim presentation under Item 1 through Item 6, covering legal proceedings, risk factors, controls and procedures, and market-risk disclosures; nothing in those items recharacterizes the reported figures. The filing evidence does not disclose segment-level detail for this dimension. The filing evidence contains no peer or industry comparison.

A reader looking for a peer-benchmarked read can compare the directional shape here with Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing, which carries the same top-line directional pattern of revenue, operating income, and diluted EPS all moving higher year over year, before forming any independent view. The filing evidence does not attribute this change to any single cause.

Operating drivers and segments

- Revenues for the three-month reporting period were $1,706,200,000 USD, compared with $1,692,000,000 USD in the prior-year quarter, and the six-month year-to-date period printed $3,586,300,000 USD versus $3,334,300,000 USD in the prior comparative window. On a year-over-year basis, both the quarter and the half-year revenue lines show an authorized increase, so the topline direction is unambiguous while any commentary on magnitude is reserved. - Operating Income (Loss) tells a more nuanced story. The three-month figure of $1,107,100,000 USD is lower than the prior-year quarter's $1,129,300,000 USD, with the authorized comparison flagging a decrease even though the result remained in profit in both periods. By contrast, the six-month Operating Income figure of $2,416,800,000 USD is higher than the prior-year comparative of $2,237,300,000 USD, again profit to profit, so the half-year operating line moved in the opposite direction to the quarter. - The combination of a lower quarter-over-quarter operating result sitting on top of higher half-year revenue and higher half-year operating income is the analytical pivot of this section, and the catalog does not authorize a numeric reconciliation of the gap. - The filing evidence does not disclose segment-level detail for this dimension. - The filing evidence contains no peer or industry comparison.

- The narrative excerpt from the filing does not include a management discussion of operating drivers, revenue mix, expense pressure, or margin trajectory for the three-month or six-month windows. The only forward-looking commentary in the quoted source is the standard cautionary language about statements "based on currently available competitive, financial and economic data," which is generic boilerplate rather than a period-specific attribution. - Because no period-specific management explanation of the quarter's lower operating result on higher revenue appears in the filing evidence, the cause side of the narrative is closed off at the source. - The filing evidence does not attribute this change to any single cause. - Readers comparing this quarter-on-quarter operating-income movement against a higher half-year operating line should note that the filing's own Item references in Part II (Item 1, Item 1A, Item 2, Item 3, Item 4, Item 5, Item 6) cover legal proceedings, risk factors, equity sales, market-risk disclosures, controls and other information rather than a revenue-by-product or segment walk, which is consistent with the absence of segment detail flagged above. - A cross-filing pattern across American National Group Inc. interim filing shows that revenue and operating income do not always move together across interim periods, and the same caution applies here: the quarter's lower operating line on higher revenue is a flagged inconsistency that requires source-level evidence before any driver story can be written, and that evidence is not in the current filing.

Cash flow and capital

- Operating cash generation strengthened over the first half, with Net Cash Provided by (Used in) Operating Activities moving higher than the prior-year comparative, leaving both periods clearly in positive territory and reinforcing the picture of a business converting profitability into cash. The six-month year-to-date period (the catalog's current period) reports a higher operating cash figure than the same window one year earlier. The filing evidence does not attribute this change to any single cause.

The filing evidence does not attribute this change to any single cause. - Investing cash usage remained negative in both six-month windows. Net Cash Provided by (Used in) Investing Activities decreased relative to the prior year, with the current period showing a deeper outflow than the comparative.

Within that investing envelope, capital spending on property, plant, and equipment (Payments to Acquire Property, Plant, and Equipment) registered higher than the prior-year comparative, indicating that the larger investing outflow partly reflects stepped-up organic investment. The filing evidence does not attribute this change to any single cause. The filing evidence does not attribute this change to any single cause.

- Financing activity flipped sign. Net Cash Provided by (Used in) Financing Activities moved from positive in the prior-year six-month window to negative in the current six-month window, a directional decrease from a source of cash to a use of cash. Cash returned to shareholders stayed a live theme: Payments of Dividends were higher than the prior-year comparative, with both periods in positive outflow territory.

The shift in financing cash flow is consistent with a heavier dividend payout and other capital-return mechanics, though the filing evidence does not attribute this change to any single cause. The filing evidence does not attribute this change to any single cause. - The balance sheet at the period end carries a Cash and Cash Equivalents, at Carrying Value position that is positive, alongside positive Accounts Payable, Current and Accounts Receivable, after Allowance for Credit Loss, Current balances.

Together these three line items describe a working-capital frame in which cash on hand is paired with both a receivables book and a payables book at the balance sheet date. The filing evidence does not disclose segment-level detail for this dimension. The filing evidence does not disclose segment-level detail for this dimension.

- Putting the three cash-flow statements side by side, operating cash inflow funded both organic capital expenditure (property, plant, and equipment) and a higher dividend payout, with the residual shortfall reflected in the swing of financing cash flow into outflow territory. The investing outflow widened year over year while operating cash inflow widened, leaving the company still generating cash from its core franchise but deploying more of it than in the prior period. The filing evidence contains no peer or industry comparison.

The filing evidence contains no peer or industry comparison. - Capital allocation in the current six-month window skews toward returning cash (higher dividends than the prior-year comparative) and toward reinvesting in the asset base (higher property, plant, and equipment payments than the prior-year comparative), rather than toward rebuilding the cash pile. The period-end Cash and Cash Equivalents, at Carrying Value remains positive, and receivables and payables both stand at positive balances at the balance sheet date, so liquidity is intact even as net cash deployment stepped up.

Readers cross-checking a comparable cash-return-versus-reinvestment setup can see a similar shape, though with a different sign pattern, in REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in Filing.

Peer and historical context

This section compares CME GROUP INC. (CME) results for the three-month reporting period and the six-month year-to-date period against the prior-year comparatives that appear in 10-Q for period-ended-2026-06-30 (accession 0001156375-26-000047). Because the filing evidence contains no external peer or industry benchmarks, every comparison below is internal — this filing versus the prior-year columns of the same filing — and any cross-company read is unavailable.

On revenue, both the quarter and the half-year comparison show higher revenue than the prior period. Revenues for the three-month reporting period were higher than the prior-year quarter ($1,706,200,000 versus $1,692,000,000), and Revenues for the six-month year-to-date period were higher than the prior-year half-year ($3,586,300,000 versus $3,334,300,000). The source narrative describes the composition of that revenue (cleared trades with variable consideration such as volume-based pricing tiers, market maker discounts and other incentives; market data and information services priced by reportable devices and subscribers; plus access and communication fees, collateral management fees, equity membership subscription fees and strategic-relationship trade-order routing fees), which gives qualitative context for how the top line is assembled but does not allocate growth to any one stream.

Operating income does not move in lockstep with revenue across the two horizons. Operating Income for the six-month year-to-date period was higher than the prior-year half-year ($2,416,800,000 versus $2,237,300,000), and Operating Income for the three-month reporting period was lower than the prior-year quarter ($1,107,100,000 versus $1,129,300,000). That pattern — half-year operating income up while quarter operating income is down — is the main divergence in the income statement on a like-for-like basis. The filing does not attribute the quarter-over-quarter operating income softness to any single cause; on that dimension the machine-level statement The filing evidence does not attribute this change to any single cause. applies.

Net Income (Loss) Attributable to Parent moves in the same direction at both horizons: higher than the prior period. Net Income for the three-month reporting period was higher than the prior-year quarter ($1,041,800,000 versus $1,025,100,000), and Net Income for the six-month year-to-date period was higher than the prior-year half-year ($2,196,100,000 versus $1,981,300,000). Both transitions are profit to profit.

Cash flow comparisons are limited to the half-year view available in the catalog. Net Cash Provided by (Used in) Operating Activities for the six-month year-to-date period was higher than the prior-year half-year ($2,207,000,000 versus $2,175,100,000).

Because the filing evidence contains no peer or industry comparison, no read-across to comparable exchange operators is possible from this filing alone; readers seeking that context can consult broader Finance Calculators Insights material outside this report.

Scenario analysis

Under the base case, CME GROUP INC. continues to convert its reported revenue base into earnings at a pace consistent with the year-to-date results filed for the six months ended June 30, 2026 and the three months ended June 30, 2026. Revenues are reported as $3,586,300,000 USD for the six-month year-to-date window and as $1,706,200,000 USD for the three-month reporting window, both higher than the prior-year comparatives of $3,334,300,000 USD for the six months ended June 30, 2025 and $1,692,000,000 USD for the three months ended June 30, 2025. Net Income (Loss) Attributable to Parent registers as $2,196,100,000 USD for the six-month window and as $1,041,800,000 USD for the quarter, exceeding the prior-year profit comparables of $1,981,300,000 USD and $1,025,100,000 USD respectively. Earnings Per Share, Diluted are authorized to read as higher in both the six-month and quarterly comparisons on a profit-to-profit basis.

The upside case assumes the revenue and net-income gains observed across both windows carry forward, with the quarterly run-rate contributing a steady cadence of recurring fees under the arrangements described in the filing. Revenues of $1,706,200,000 USD against $1,692,000,000 USD would be sustained or extended, and the six-month figure of $3,586,300,000 USD versus $3,334,300,000 USD would reinforce a positive trend. Net Income Attributable to Parent of $1,041,800,000 USD versus $1,025,100,000 USD and of $2,196,100,000 USD versus $1,981,300,000 USD would remain in profit on both a quarter and year-to-date basis, supporting the authorized direction on Earnings Per Share, Diluted.

The downside case envisions a reversal in either the revenue base or the earnings conversion observed for the six months ended June 30, 2026 and the three months ended June 30, 2026. A slip from the reported $3,586,300,000 USD or $1,706,200,000 USD toward the prior-year levels of $3,334,300,000 USD and $1,692,000,000 USD would compress the top line. Net Income Attributable to Parent could retreat from $2,196,100,000 USD and $1,041,800,000 USD toward the prior-year comparables of $1,981,300,000 USD and $1,025,100,000 USD, though the authorized comparisons frame both periods as profit to profit on a diluted-EPS basis.

In every scenario, the underlying revenue mix is supported by recurring mechanisms described in the filing — annual license fees recognized monthly, access and communication fees billed monthly, collateral management fees calculated on daily collateral balances, equity membership subscription fees earned monthly, and strategic-relationship fees recognized as billed — which provide a stable cadence against which the three-month and six-month totals can be assessed. The directional moves in Revenues, Net Income Attributable to Parent, and Earnings Per Share, Diluted are the only year-over-year relations the filing evidence authorizes for 10-Q filed under 0001156375-26-000047 for period-ended-2026-06-30, and no segment-level breakdown is supplied. The filing evidence does not attribute this change to any single cause. The filing evidence contains no peer or industry comparison. The filing evidence does not disclose segment-level detail for this dimension.

Risks and what to watch

- Reported facts in this filing are limited to top-line revenue and bottom-line net income attributable to parent for the three-month and six-month reporting windows, with prior-year comparatives, drawn from 10-Q period-ended-2026-06-30 for CME GROUP INC. (CME) under 0001156375-26-000047. Revenues for the three-month period stood at $1,706,200,000, against $1,692,000,000 in the prior-year quarter, a higher-than-prior-period outcome.

The six-month figure reached $3,586,300,000, compared with $3,334,300,000, also higher than the prior period. Net Income (Loss) Attributable to Parent for the three-month period was $1,041,800,000, versus $1,025,100,000 in the prior-year quarter, an authorized increase from a profit to a higher profit. The six-month net income was $2,196,100,000, against $1,981,300,000 in the prior-year six-month window, again an authorized increase from a profit to a higher profit.

The filing evidence does not attribute this change to any single cause. - Management explanations drawn from the source narrative frame revenue risk around the timing of customer payments: certain transaction fees, annual licenses, and other revenue arrangements are billed upfront before revenue is recognized, creating contract liabilities on the consolidated balance sheets that unwind as obligations are satisfied. Management notes that changes in the contract liability balances during the second quarter were not materially impacted by any other factors.

Additional management commentary covers fee revenue earned monthly under a program where clients may elect to pay a fee in lieu of holding Class A shares, with pricing for strategic relationships tied to customer levels and activity, and revenue recognized monthly as customers receive and consume the benefits of the services. Performance bonds and guaranty fund contributions are described as reinvested across commercial and central bank deposits, government securities, reverse repurchase agreements, and money market funds, with a portion of the interest distributed back to clearing firms.

The cited note also confirms CME's designation as a systemically important financial market utility by the Financial Stability Oversight Council. - Analyst inference is constrained by what is and is not disclosed. The authorized comparators confirm revenue and net income both moved higher year over year in both windows, with operating income over the six months also higher and diluted earnings per share higher, while the three-month operating income moved lower against the prior-year quarter.

The filing evidence does not attribute this change to any single cause. The narrative does not attribute these movements to any single driver, so any read on mix shift, contract-liability drawdown, or reinvestment yield is not supported by the filing evidence. - Counter-evidence is equally thin.

The filing evidence does not disclose segment-level detail for this dimension. No segment-level detail is disclosed for revenue or net income, so a reader cannot verify the composition of the higher top line across transaction volumes, market-data and information services, clearing and transaction fees, or contract-liability releases. The filing evidence contains no peer or industry comparison.

The filing contains no peer or industry comparison, leaving relative positioning against other derivatives exchanges or FMUs unaddressed. The reference items that frame this 10-Q-style filing — Item 1A on Risk Factors, Item 3 on Quantitative and Qualitative Disclosures About Market Risk, and Item 4 on Controls and Procedures — are referenced but their substance is not reproduced here, so any regulatory, litigation, or internal-control matter that would offset the year-over-year gain is outside the scope of the filing evidence.

- Unknowns worth flagging: the size and timing of contract-liability releases; any incremental contribution from strategic-relationship fee arrangements; the yield profile on the performance-bond and guaranty-fund reinvestment book and its sensitivity to short-rate moves; and the segment composition of the revenue and net income gains. - Metrics to watch next period: the three-month and six-month revenue trend against the newly elevated base, the contract-liability balance and its runoff, operating income in the three-month window where the authorized direction this period was a decrease, diluted EPS continuation of the authorized increase, and any risk-factor or market-risk update surfaced through Item 1A and Item 3.

Readers comparing this trajectory against peers can cross-check with REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in period-ended-2026-06-30 Filing and Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in the reporting period Filing for additional year-over-year gain patterns.